TP53-PTEN-NF1 Depletion in Human Brain Organoids Produces a Glioma Phenotype

Authors

Sanjay K Singh
Yan Wang
Ahmed Habib
Mamindla Priyadarshini
Chowdari V Kodavali
Apeng Chen
Wencai Ma
Jing Wang
N U Farrukh Hameed
Baoli Hu
Gregory N Fuller
Scott M Kulich
Nduka Amankulor
Rivka R Colen
Lincoln A Edwards
Pascal O Zinn

Publication Date

1-1-2023

Journal

Frontiers in Oncology

Abstract

Glioblastoma (GBM) is fatal and the study of therapeutic resistance, disease progression, and drug discovery in GBM or glioma stem cells is often hindered by limited resources. This limitation slows down progress in both drug discovery and patient survival. Here we present a genetically engineered human cerebral organoid model with a cancer-like phenotype that could provide a basis for GBM-like models. Specifically, we engineered a doxycycline-inducible vector encoding shRNAs enabling depletion of the TP53, PTEN, and NF1 tumor suppressors in human cerebral organoids. Designated as inducible short hairpin-TP53-PTEN-NF1 (ish-TPN), doxycycline treatment resulted in human cancer-like cerebral organoids that effaced the entire organoid cytoarchitecture, while uninduced ish-TPN cerebral organoids recapitulated the normal cytoarchitecture of the brain. Transcriptomic analysis revealed a proneural GBM subtype. This proof-of-concept study offers a valuable resource for directly investigating the emergence and progression of gliomas within the context of specific genetic alterations in normal cerebral organoids.

Keywords

organoid, nestin, glioblastoma, TP53, PTEN, and NF1 tumor suppressors, proneural GBM subtype

Comments

This corrects the article " TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions" on page 2516.

DOI

10.3389/fonc.2023.1279806

PMID

37881491

PMCID

PMC10597663

PubMedCentral® Posted Date

October 2023

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes